Cargando…
Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405912/ https://www.ncbi.nlm.nih.gov/pubmed/37555191 http://dx.doi.org/10.2147/IJN.S431592 |
Ejemplares similares
-
Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer
por: Dang, Wenli, et al.
Publicado: (2023) -
Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
Publicado: (2015) -
Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
Publicado: (2019) -
Corrigendum to “Getting in Touch is an Important Step: Control of Metabolism
at Organelle Contact Sites”
Publicado: (2021) -
Cell- and subcellular organelle-targeting nanoparticle-mediated breast cancer therapy
por: Wei, Xue, et al.
Publicado: (2023)